← 產業報告目錄
Depression Treatment Device Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 128報告編號 APO-259a2b32c0
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Depression Treatment Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Depression Treatment Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Depression Treatment Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Depression Treatment Device include Alpha-Stim, BrainsWay, Caputron Medical, Electromedical Products International, Inc., Fisher Wallace Laboratories, Flow Neuroscience, Flow Neuroscience AB, Ginger and INNOVATIVE NEUROLOGICAL Devices LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Depression Treatment Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Depression Treatment Device Market by Company
Alpha-Stim
BrainsWay
Caputron Medical
Electromedical Products International, Inc.
Fisher Wallace Laboratories
Flow Neuroscience
Flow Neuroscience AB
Ginger
INNOVATIVE NEUROLOGICAL Devices LLC
Magnus Medical
Neurolief
Neuronetics
NeuroStar
The Magstim Company Limited
Depression Treatment Device Segment by Type
Transcranial Direct Current Stimulation (tDCS)
Transcranial Random Noise Stimulation (tRNS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Alternating Current Stimulation (tACS)
Electroconvulsive therapy (ECT)
Others
Depression Treatment Device Segment by Application
Hospital
Clinic
Others
Depression Treatment Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression Treatment Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Depression Treatment Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression Treatment Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Depression Treatment Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Depression Treatment Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Depression Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Depression Treatment Device Market Size (2021-2032)
2.2.2 Global Depression Treatment Device Sales (2021-2032)
2.2.3 Global Depression Treatment Device Market Average Price (2021-2032)
2.3 Depression Treatment Device by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Transcranial Direct Current Stimulation (tDCS)
2.3.3 Transcranial Random Noise Stimulation (tRNS)
2.3.4 Transcranial Pulsed Current Stimulation (tPCS)
2.3.5 Transcranial Alternating Current Stimulation (tACS)
2.3.6 Electroconvulsive therapy (ECT)
2.3.7 Others
2.4 Depression Treatment Device by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Depression Treatment Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Depression Treatment Device Sales (k units) of Manufacturers (2021-2026)
3.3 Global Depression Treatment Device Revenue of Manufacturers (2021-2026)
3.4 Global Depression Treatment Device Average Price by Manufacturers (2021-2026)
3.5 Global Depression Treatment Device Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Depression Treatment Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Depression Treatment Device, Product Type & Application
3.8 Global Manufacturers of Depression Treatment Device, Established Date
3.9 Global Depression Treatment Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Alpha-Stim
4.1.1 Alpha-Stim Company Information
4.1.2 Alpha-Stim Business Overview
4.1.3 Alpha-Stim Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Alpha-Stim Depression Treatment Device Product Portfolio
4.1.5 Alpha-Stim Recent Developments
4.2 BrainsWay
4.2.1 BrainsWay Company Information
4.2.2 BrainsWay Business Overview
4.2.3 BrainsWay Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.2.4 BrainsWay Depression Treatment Device Product Portfolio
4.2.5 BrainsWay Recent Developments
4.3 Caputron Medical
4.3.1 Caputron Medical Company Information
4.3.2 Caputron Medical Business Overview
4.3.3 Caputron Medical Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Caputron Medical Depression Treatment Device Product Portfolio
4.3.5 Caputron Medical Recent Developments
4.4 Electromedical Products International, Inc.
4.4.1 Electromedical Products International, Inc. Company Information
4.4.2 Electromedical Products International, Inc. Business Overview
4.4.3 Electromedical Products International, Inc. Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Electromedical Products International, Inc. Depression Treatment Device Product Portfolio
4.4.5 Electromedical Products International, Inc. Recent Developments
4.5 Fisher Wallace Laboratories
4.5.1 Fisher Wallace Laboratories Company Information
4.5.2 Fisher Wallace Laboratories Business Overview
4.5.3 Fisher Wallace Laboratories Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Fisher Wallace Laboratories Depression Treatment Device Product Portfolio
4.5.5 Fisher Wallace Laboratories Recent Developments
4.6 Flow Neuroscience
4.6.1 Flow Neuroscience Company Information
4.6.2 Flow Neuroscience Business Overview
4.6.3 Flow Neuroscience Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Flow Neuroscience Depression Treatment Device Product Portfolio
4.6.5 Flow Neuroscience Recent Developments
4.7 Flow Neuroscience AB
4.7.1 Flow Neuroscience AB Company Information
4.7.2 Flow Neuroscience AB Business Overview
4.7.3 Flow Neuroscience AB Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Flow Neuroscience AB Depression Treatment Device Product Portfolio
4.7.5 Flow Neuroscience AB Recent Developments
4.8 Ginger
4.8.1 Ginger Company Information
4.8.2 Ginger Business Overview
4.8.3 Ginger Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Ginger Depression Treatment Device Product Portfolio
4.8.5 Ginger Recent Developments
4.9 INNOVATIVE NEUROLOGICAL Devices LLC
4.9.1 INNOVATIVE NEUROLOGICAL Devices LLC Company Information
4.9.2 INNOVATIVE NEUROLOGICAL Devices LLC Business Overview
4.9.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.9.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio
4.9.5 INNOVATIVE NEUROLOGICAL Devices LLC Recent Developments
4.10 Magnus Medical
4.10.1 Magnus Medical Company Information
4.10.2 Magnus Medical Business Overview
4.10.3 Magnus Medical Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Magnus Medical Depression Treatment Device Product Portfolio
4.10.5 Magnus Medical Recent Developments
4.11 Neurolief
4.11.1 Neurolief Company Information
4.11.2 Neurolief Business Overview
4.11.3 Neurolief Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Neurolief Depression Treatment Device Product Portfolio
4.11.5 Neurolief Recent Developments
4.12 Neuronetics
4.12.1 Neuronetics Company Information
4.12.2 Neuronetics Business Overview
4.12.3 Neuronetics Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Neuronetics Depression Treatment Device Product Portfolio
4.12.5 Neuronetics Recent Developments
4.13 NeuroStar
4.13.1 NeuroStar Company Information
4.13.2 NeuroStar Business Overview
4.13.3 NeuroStar Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.13.4 NeuroStar Depression Treatment Device Product Portfolio
4.13.5 NeuroStar Recent Developments
4.14 The Magstim Company Limited
4.14.1 The Magstim Company Limited Company Information
4.14.2 The Magstim Company Limited Business Overview
4.14.3 The Magstim Company Limited Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
4.14.4 The Magstim Company Limited Depression Treatment Device Product Portfolio
4.14.5 The Magstim Company Limited Recent Developments
5 Global Depression Treatment Device Market Scenario by Region
5.1 Global Depression Treatment Device Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Depression Treatment Device Sales by Region: 2021-2032
5.2.1 Global Depression Treatment Device Sales by Region: 2021-2026
5.2.2 Global Depression Treatment Device Sales by Region: 2027-2032
5.3 Global Depression Treatment Device Revenue by Region: 2021-2032
5.3.1 Global Depression Treatment Device Revenue by Region: 2021-2026
5.3.2 Global Depression Treatment Device Revenue by Region: 2027-2032
5.4 North America Depression Treatment Device Market Facts & Figures by Country
5.4.1 North America Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Depression Treatment Device Sales by Country (2021-2032)
5.4.3 North America Depression Treatment Device Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Depression Treatment Device Market Facts & Figures by Country
5.5.1 Europe Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Depression Treatment Device Sales by Country (2021-2032)
5.5.3 Europe Depression Treatment Device Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Depression Treatment Device Market Facts & Figures by Country
5.6.1 Asia Pacific Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Depression Treatment Device Sales by Country (2021-2032)
5.6.3 Asia Pacific Depression Treatment Device Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Depression Treatment Device Market Facts & Figures by Country
5.7.1 South America Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Depression Treatment Device Sales by Country (2021-2032)
5.7.3 South America Depression Treatment Device Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Depression Treatment Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Depression Treatment Device Sales by Country (2021-2032)
5.8.3 Middle East and Africa Depression Treatment Device Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Depression Treatment Device Sales by Type (2021-2032)
6.1.1 Global Depression Treatment Device Sales by Type (2021-2032) & (k units)
6.1.2 Global Depression Treatment Device Sales Market Share by Type (2021-2032)
6.2 Global Depression Treatment Device Revenue by Type (2021-2032)
6.2.1 Global Depression Treatment Device Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Depression Treatment Device Revenue Market Share by Type (2021-2032)
6.3 Global Depression Treatment Device Price by Type (2021-2032)
7 Segment by Application
7.1 Global Depression Treatment Device Sales by Application (2021-2032)
7.1.1 Global Depression Treatment Device Sales by Application (2021-2032) & (k units)
7.1.2 Global Depression Treatment Device Sales Market Share by Application (2021-2032)
7.2 Global Depression Treatment Device Revenue by Application (2021-2032)
7.2.1 Global Depression Treatment Device Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Depression Treatment Device Revenue Market Share by Application (2021-2032)
7.3 Global Depression Treatment Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Depression Treatment Device Value Chain Analysis
8.1.1 Depression Treatment Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Depression Treatment Device Production Mode & Process
8.2 Depression Treatment Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Depression Treatment Device Distributors
8.2.3 Depression Treatment Device Customers
9 Global Depression Treatment Device Analyzing Market Dynamics
9.1 Depression Treatment Device Industry Trends
9.2 Depression Treatment Device Industry Drivers
9.3 Depression Treatment Device Industry Opportunities and Challenges
9.4 Depression Treatment Device Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Depression Treatment Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Depression Treatment Device Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Depression Treatment Device Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Depression Treatment Device Revenue of Manufacturers (2021-2026)
Table 9. Global Depression Treatment Device Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Depression Treatment Device Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Depression Treatment Device Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Depression Treatment Device, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Depression Treatment Device, Product Type & Application
Table 14. Global Depression Treatment Device Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Depression Treatment Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Alpha-Stim Company Information
Table 19. Alpha-Stim Business Overview
Table 20. Alpha-Stim Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Alpha-Stim Depression Treatment Device Product Portfolio
Table 22. Alpha-Stim Recent Developments
Table 23. BrainsWay Company Information
Table 24. BrainsWay Business Overview
Table 25. BrainsWay Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. BrainsWay Depression Treatment Device Product Portfolio
Table 27. BrainsWay Recent Developments
Table 28. Caputron Medical Company Information
Table 29. Caputron Medical Business Overview
Table 30. Caputron Medical Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Caputron Medical Depression Treatment Device Product Portfolio
Table 32. Caputron Medical Recent Developments
Table 33. Electromedical Products International, Inc. Company Information
Table 34. Electromedical Products International, Inc. Business Overview
Table 35. Electromedical Products International, Inc. Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Electromedical Products International, Inc. Depression Treatment Device Product Portfolio
Table 37. Electromedical Products International, Inc. Recent Developments
Table 38. Fisher Wallace Laboratories Company Information
Table 39. Fisher Wallace Laboratories Business Overview
Table 40. Fisher Wallace Laboratories Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Fisher Wallace Laboratories Depression Treatment Device Product Portfolio
Table 42. Fisher Wallace Laboratories Recent Developments
Table 43. Flow Neuroscience Company Information
Table 44. Flow Neuroscience Business Overview
Table 45. Flow Neuroscience Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Flow Neuroscience Depression Treatment Device Product Portfolio
Table 47. Flow Neuroscience Recent Developments
Table 48. Flow Neuroscience AB Company Information
Table 49. Flow Neuroscience AB Business Overview
Table 50. Flow Neuroscience AB Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Flow Neuroscience AB Depression Treatment Device Product Portfolio
Table 52. Flow Neuroscience AB Recent Developments
Table 53. Ginger Company Information
Table 54. Ginger Business Overview
Table 55. Ginger Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Ginger Depression Treatment Device Product Portfolio
Table 57. Ginger Recent Developments
Table 58. INNOVATIVE NEUROLOGICAL Devices LLC Company Information
Table 59. INNOVATIVE NEUROLOGICAL Devices LLC Business Overview
Table 60. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio
Table 62. INNOVATIVE NEUROLOGICAL Devices LLC Recent Developments
Table 63. Magnus Medical Company Information
Table 64. Magnus Medical Business Overview
Table 65. Magnus Medical Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Magnus Medical Depression Treatment Device Product Portfolio
Table 67. Magnus Medical Recent Developments
Table 68. Neurolief Company Information
Table 69. Neurolief Business Overview
Table 70. Neurolief Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Neurolief Depression Treatment Device Product Portfolio
Table 72. Neurolief Recent Developments
Table 73. Neuronetics Company Information
Table 74. Neuronetics Business Overview
Table 75. Neuronetics Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Neuronetics Depression Treatment Device Product Portfolio
Table 77. Neuronetics Recent Developments
Table 78. NeuroStar Company Information
Table 79. NeuroStar Business Overview
Table 80. NeuroStar Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. NeuroStar Depression Treatment Device Product Portfolio
Table 82. NeuroStar Recent Developments
Table 83. The Magstim Company Limited Company Information
Table 84. The Magstim Company Limited Business Overview
Table 85. The Magstim Company Limited Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. The Magstim Company Limited Depression Treatment Device Product Portfolio
Table 87. The Magstim Company Limited Recent Developments
Table 88. Global Depression Treatment Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 89. Global Depression Treatment Device Sales by Region (2021-2026) & (k units)
Table 90. Global Depression Treatment Device Sales Market Share by Region (2021-2026)
Table 91. Global Depression Treatment Device Sales by Region (2027-2032) & (k units)
Table 92. Global Depression Treatment Device Sales Market Share by Region (2027-2032)
Table 93. Global Depression Treatment Device Revenue by Region (2021-2026) & (US$ Million)
Table 94. Global Depression Treatment Device Revenue Market Share by Region (2021-2026)
Table 95. Global Depression Treatment Device Revenue by Region (2027-2032) & (US$ Million)
Table 96. Global Depression Treatment Device Revenue Market Share by Region (2027-2032)
Table 97. North America Depression Treatment Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. North America Depression Treatment Device Sales by Country (2021-2026) & (k units)
Table 99. North America Depression Treatment Device Sales by Country (2027-2032) & (k units)
Table 100. North America Depression Treatment Device Revenue by Country (2021-2026) & (US$ Million)
Table 101. North America Depression Treatment Device Revenue by Country (2027-2032) & (US$ Million)
Table 102. Europe Depression Treatment Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. Europe Depression Treatment Device Sales by Country (2021-2026) & (k units)
Table 104. Europe Depression Treatment Device Sales by Country (2027-2032) & (k units)
Table 105. Europe Depression Treatment Device Revenue by Country (2021-2026) & (US$ Million)
Table 106. Europe Depression Treatment Device Revenue by Country (2027-2032) & (US$ Million)
Table 107. Asia Pacific Depression Treatment Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. Asia Pacific Depression Treatment Device Sales by Country (2021-2026) & (k units)
Table 109. Asia Pacific Depression Treatment Device Sales by Country (2027-2032) & (k units)
Table 110. Asia Pacific Depression Treatment Device Revenue by Country (2021-2026) & (US$ Million)
Table 111. Asia Pacific Depression Treatment Device Revenue by Country (2027-2032) & (US$ Million)
Table 112. South America Depression Treatment Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. South America Depression Treatment Device Sales by Country (2021-2026) & (k units)
Table 114. South America Depression Treatment Device Sales by Country (2027-2032) & (k units)
Table 115. South America Depression Treatment Device Revenue by Country (2021-2026) & (US$ Million)
Table 116. South America Depression Treatment Device Revenue by Country (2027-2032) & (US$ Million)
Table 117. Middle East and Africa Depression Treatment Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Middle East and Africa Depression Treatment Device Sales by Country (2021-2026) & (k units)
Table 119. Middle East and Africa Depression Treatment Device Sales by Country (2027-2032) & (k units)
Table 120. Middle East and Africa Depression Treatment Device Revenue by Country (2021-2026) & (US$ Million)
Table 121. Middle East and Africa Depression Treatment Device Revenue by Country (2027-2032) & (US$ Million)
Table 122. Global Depression Treatment Device Sales by Type (2021-2026) & (k units)
Table 123. Global Depression Treatment Device Sales by Type (2027-2032) & (k units)
Table 124. Global Depression Treatment Device Sales Market Share by Type (2021-2026)
Table 125. Global Depression Treatment Device Sales Market Share by Type (2027-2032)
Table 126. Global Depression Treatment Device Revenue by Type (2021-2026) & (US$ Million)
Table 127. Global Depression Treatment Device Revenue by Type (2027-2032) & (US$ Million)
Table 128. Global Depression Treatment Device Revenue Market Share by Type (2021-2026)
Table 129. Global Depression Treatment Device Revenue Market Share by Type (2027-2032)
Table 130. Global Depression Treatment Device Price by Type (2021-2026) & (USD/unit)
Table 131. Global Depression Treatment Device Price by Type (2027-2032) & (USD/unit)
Table 132. Global Depression Treatment Device Sales by Application (2021-2026) & (k units)
Table 133. Global Depression Treatment Device Sales by Application (2027-2032) & (k units)
Table 134. Global Depression Treatment Device Sales Market Share by Application (2021-2026)
Table 135. Global Depression Treatment Device Sales Market Share by Application (2027-2032)
Table 136. Global Depression Treatment Device Revenue by Application (2021-2026) & (US$ Million)
Table 137. Global Depression Treatment Device Revenue by Application (2027-2032) & (US$ Million)
Table 138. Global Depression Treatment Device Revenue Market Share by Application (2021-2026)
Table 139. Global Depression Treatment Device Revenue Market Share by Application (2027-2032)
Table 140. Global Depression Treatment Device Price by Application (2021-2026) & (USD/unit)
Table 141. Global Depression Treatment Device Price by Application (2027-2032) & (USD/unit)
Table 142. Key Raw Materials
Table 143. Raw Materials Key Suppliers
Table 144. Depression Treatment Device Distributors List
Table 145. Depression Treatment Device Customers List
Table 146. Depression Treatment Device Industry Trends
Table 147. Depression Treatment Device Industry Drivers
Table 148. Depression Treatment Device Industry Restraints
Table 149. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Depression Treatment Device Product Image
Figure 5. Global Depression Treatment Device Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Depression Treatment Device Market Size (2021-2032) & (US$ Million)
Figure 7. Global Depression Treatment Device Sales (2021-2032) & (k units)
Figure 8. Global Depression Treatment Device Average Price (USD/unit) & (2021-2032)
Figure 9. Transcranial Direct Current Stimulation (tDCS) Product Image
Figure 10. Transcranial Random Noise Stimulation (tRNS) Product Image
Figure 11. Transcranial Pulsed Current Stimulation (tPCS) Product Image
Figure 12. Transcranial Alternating Current Stimulation (tACS) Product Image
Figure 13. Electroconvulsive therapy (ECT) Product Image
Figure 14. Others Product Image
Figure 15. Hospital Product Image
Figure 16. Clinic Product Image
Figure 17. Others Product Image
Figure 18. Global Depression Treatment Device Revenue Share by Manufacturers in 2025
Figure 19. Global Manufacturers of Depression Treatment Device, Manufacturing Sites & Headquarters
Figure 20. Global Top 5 and 10 Depression Treatment Device Players Market Share by Revenue in 2025
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. Global Depression Treatment Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 23. Global Depression Treatment Device Sales by Region in 2025
Figure 24. Global Depression Treatment Device Revenue by Region in 2025
Figure 25. North America Depression Treatment Device Market Size by Country in 2025
Figure 26. North America Depression Treatment Device Sales Market Share by Country (2021-2032)
Figure 27. North America Depression Treatment Device Revenue Market Share by Country (2021-2032)
Figure 28. United States Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Canada Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. Mexico Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Europe Depression Treatment Device Market Size by Country in 2025
Figure 32. Europe Depression Treatment Device Sales Market Share by Country (2021-2032)
Figure 33. Europe Depression Treatment Device Revenue Market Share by Country (2021-2032)
Figure 34. Germany Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. France Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. U.K. Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Italy Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Russia Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Spain Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Netherlands Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Switzerland Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Sweden Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Poland Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Asia Pacific Depression Treatment Device Market Size by Country in 2025
Figure 45. Asia Pacific Depression Treatment Device Sales Market Share by Country (2021-2032)
Figure 46. Asia Pacific Depression Treatment Device Revenue Market Share by Country (2021-2032)
Figure 47. China Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Japan Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. South Korea Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. India Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Australia Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Taiwan Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Southeast Asia Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Southeast Asia Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. South America Depression Treatment Device Market Size by Country in 2025
Figure 56. South America Depression Treatment Device Sales Market Share by Country (2021-2032)
Figure 57. South America Depression Treatment Device Revenue Market Share by Country (2021-2032)
Figure 58. Brazil Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Argentina Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Chile Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Colombia Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Middle East and Africa Depression Treatment Device Market Size by Country in 2025
Figure 63. Middle East and Africa Depression Treatment Device Sales Market Share by Country (2021-2032)
Figure 64. Middle East and Africa Depression Treatment Device Revenue Market Share by Country (2021-2032)
Figure 65. Egypt Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. South Africa Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Israel Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 68. Türkiye Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 69. GCC Countries Depression Treatment Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 70. Global Depression Treatment Device Sales Market Share by Type (2021-2032)
Figure 71. Global Depression Treatment Device Revenue Market Share by Type (2021-2032)
Figure 72. Global Depression Treatment Device Price (USD/unit) by Type (2021-2032)
Figure 73. Global Depression Treatment Device Sales Market Share by Application (2021-2032)
Figure 74. Global Depression Treatment Device Revenue Market Share by Application (2021-2032)
Figure 75. Global Depression Treatment Device Price (USD/unit) by Application (2021-2032)
Figure 76. Depression Treatment Device Value Chain
Figure 77. Depression Treatment Device Production Mode & Process
Figure 78. Direct Comparison with Distribution Share
Figure 79. Distributors Profiles
Figure 80. Depression Treatment Device Industry Opportunities and Challenges
提及公司
Alpha-StimBrainsWayCaputron MedicalElectromedical Products International, Inc.Fisher Wallace LaboratoriesFlow NeuroscienceFlow Neuroscience ABGingerINNOVATIVE NEUROLOGICAL Devices LLCMagnus MedicalNeuroliefNeuroneticsNeuroStarThe Magstim Company Limited
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們